Odesa National Medical University MH of Ukraine, Odesa, Ukraine
DOI 10.54229/2226-2008-2021-5-7
Сerebral palsy (CP) occupies a significant place in the structure of neurological pathology of childhood, which is connected with comorbid pathology, such as pneumonia, which is characterized by a long and atypical course, and associates with frequent development of complications.
Aims. The aim was to determinate the main features of the course and identify microbiological agents of community-acquired pneumonia (CAP) in children with cerebral palsy.
Methods. The cases of CAP in children with cerebral palsy was retrospectively studied. Children with CAP have been treated in the Children’s City Clinical Hospital No. 3 of the Odesa between 2018 to 2020. The main typical clinical signs were analyzed. The microbiological agents were investigated by the microbiological examination of sputum.
Results. Community-acquired pneumonia in children with cerebral palsy has its own specific features. Onset of the disease is characterized by a significant severity of the general condition, rapid progression of intoxication in children with cerebral palsy. Resistant agents and Candida albicans were identified in children with cerebral palsy.
Conclusions. The studied features will help pediatricians in CAP assessment in patients with cerebral palsy, and it will be useful in the management of antibiotic therapy in these patients.
Key words: community-acquired pneumonia, cerebral palsy, microbiogical agents.
References
- Abdrakhmanova SТ, Skuchalina LN, Ajshurova RS. Features of respiratory pathology in children with central nervous system lesions. Valeologiia. 2014;4:12-14. (In Russian).
- Aishaurova RR, Skuchalina LN, Abdrakhmanova SТ, Mescheriakov VV. Features of community-acquired pneumonia in children with cerebral palsy. Pediatrics. 2018;5(149):14-18. (In Russian).
- Millman AJ, Finelli L, Bramley AM, Peacock G, Williams DJ, Arnold SR. et al. Community-Acquired Pneumonia Hospitalization among Children with Neurologic Disorders. J. Pediatr. 2016;173:188-95.
- Hull J., Aniapravan R., Chan E., Chatwin M., Forton J., Gallagher J., Gibson N., Gordon J., Hughes I., McCulloch R. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax. 2012;67:1.
- Farrero E, Egea CJ. Pulmonary complications of neuromuscular disease:clinical guidelines of the s spanish society of pulmonology and thoracic surgery. Guidelines for the management of respiratory complications in patients with neuromuskular disease. 2013;49(7):306-313.
- Hull J, Aniapravan R, Chan E, Chatwin M, Forton J, Gallagher J. et al. British Thoracic Society guideline for respiratory management of children with neuromuscular weakness. Thorax. 2012;67:1-40.
- Thomson J. Diagnostic Testing and Hospital Outcomes of Children with Neurologic Impairment and Bacterial Pneumonia. J. Pediatr. 2016;178:156-163.
- Toder DS. Respiratory problems in the adolescent with developmental delay. Adolesc. Med. 2000;11: 617-631.
- Reddihough DS. Cerebral palsy in Victoria, Australia: mortality and causes of death. J. Paediatr. Child Health. 2001;37:183-186.